

Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0142|119|19|3570-3577
ISSN: 0008-543x
Source: CANCER, Vol.119, Iss.19, 2013-10, pp. : 3570-3577
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. :








Oxaliplatin-Induced Lhermitte’s Phenomenon as a Manifestation of Severe Generalized Neurotoxicity
Oncology, Vol. 77, Iss. 6, 2009-12 ,pp. :